The Kirsch Lab uses sophisticated genetically engineered mouse models, cellular and molecular biology, and biochemistry to study cancer and radiation biology. Our research ranges from fundamental basic questions into the mechanisms by which tumor suppressor genes prevent cancer to translational projects that focus on mechanisms of metastasis, tumor response to radiation therapy and normal tissue injury from radiation. In a collaborative environment, we work together to make discoveries and strive to translate our research into clinical trials for patients with cancer.
We use Cre-loxP technology to delete genes in a cell-type specific manner and apply sophisticated small animal irradiation to study mechanisms of radiation injury and regeneration in the intestine and other tissues.
We study mechanisms of sarcoma development and tumour maintenance in undifferentiated small round cell sarcoma driven by the CIC::DUX4 fusion oncoprotein and in epithelioid sarcoma initiated by loss of SMARCB1, a subunit of the SWI/SNF protein complex.
Using autochthonous sarcoma models, we study mechanisms of tumour response to radiotherapy alone or to a combination of radiation and immunotherapy.
We study mechanisms of tumour suppression by the three genes most frequently mutated in complex karyotype sarcomas: p53, Rb, and ATRX.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.